How safe is your money in Brambles Limited?

Brambles Limited (ASX:BXB) reported sales growth on Wednesday. But the logistic company's good news was dashed by irate shareholders and a potential class action.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was a big day for Brambles Limited (ASX: BXB) yesterday.

The supply chain and logistics company fended off shareholder backlash at its AGM, announced its first quarter trading update, and dealt with a potential class action.

Law firm Maurice Blackburn is calling on Brambles shareholders to join the class action which would seek to prove that Brambles effectively misled the market.

The potential action centres on the claim that in August 2016 Brambles gave guidance regarding sales growth of 7% to 9% and profit growth of 9% to 11%.

Brambles repeated this guidance on 20 October 2016 when it published its trading update for the first quarter of 2017, and again on 16 November 2016 at its AGM, according to the law firm.

Then, in January 2017, Brambles said it no longer expected to meet its earlier guidance but expected sales growth of 5% and profit growth of 3% for the first half of FY17 and sales and profit growth for FY17 to be below the guidance previously provided.

In February 2017, Brambles published its results for the first half of FY17, providing revised guidance of sales growth around 5% and profit growth of 0%, according to Maurice Blackburn.

"The market reacted strongly, with price drops of almost 16% on 23 January 2017 (with a trading volume of 19.3 million) and 10% on 20 February 2017 (with a trading volume of 21.7 million, around five times greater than the average volume over the previous 12 months)," the law firm stated.

"Companies are required to have a reasonable basis for their guidance and must notify the ASX as soon as they have or ought to have information which would cast doubt on prior guidance."

Maurice Blackburn claims its investigations "raise serious questions as to whether Brambles had a reasonable basis for its initial guidance and whether it should have notified the ASX sooner" that it was likely it would miss those targets.

If Brambles lacked a reasonable basis for its guidance, investors (who purchased Brambles shares between 20 October 2016 and 19 February 2017) may have paid an inflated price for Brambles shares, and they may be able to recover their losses through this potential class action, according to Maurice Blackburn.

Brambles said it's aware of the potential case against it and said it intends to fight any action.

"Brambles has not received any formal communication nor has it been served with any proceeding and so is not able to comment further," Brambles stated.

"However, Brambles strongly believes that it has at all times complied with its continuous disclosure and other regulatory obligations.

"Brambles therefore intends to vigorously defend any action if filed."

Brambles now joins a list of companies, including the Commonwealth Bank of Australia (ASX: CBA), Woolworths Limited (ASX: WOW), Crown Resorts Limited (ASX:CWN), Bellamy's Australia Ltd (ASX: BAL) and Aveo Group (ASX: AOG), facing class actions or potential class actions by Maurice Blackburn.

Brambles CEO Graham Chipchase and Chairman Stephen Johns also had to fend off attacks from investors who voiced numerous concerns, one centring on executive pay, at the company's AGM.

But Brambles did have some good news. The company announced its first quarter sales for FY18 had increased 6%, prompting its share price to gain 0.76% and close at $9.33.

Motley Fool contributor Steve Holland has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »